Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
Randomized open label clinical trial to compare the clinical and microbiological efficacy of
fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium
difficile infection